21 completed, 4 terminated, 2 recruiting, 2 unknown. 31 Phase 2, 4 Phase 1, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 31 | Completed 21, Terminated 4, Recruiting 2, Unknown 2, Active not recruiting 1, Withdrawn 1 |
| Phase 1 | 4 | Completed 4 |
| Phase 3 | 2 | Completed 2 |
Follow perampanel: new trials by email Literature Review of perampanel trials Research Report on perampanel
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PeRampanel fOr Status ePilEpticus pRophylaxis Post-cardiac Arrest Perampanel, Placebo - Heart Arrest, Seizures | Phase 2 | Recruiting | University of California, San Francisco | 52 | 2024-05-20 | 2026-07-29 |
| The Impact of AMPA Receptor Blockade on Ketamine's Anti-Suicidal Effects Perampanel 6 MG, Ketamine, Placebo - Depressive Disorder, Major Depressive Disorder | Phase 2 | Recruiting | Yale University | 30 | 2023-04-03 | 2026-05-06 |
| Effect of Perampanel on Peritumoral Hyperexcitability in HGG Perampanel, Standard of Care - Glioma, Malignant, Surgery | Phase 1 / Phase 2 | Completed | Dana-Farber Cancer Institute | 12 | 2020-11-05 | 2024-08-05 |
| Open Label Pilot Study of Perampanel for the Treatment of Alcohol Use Disorder Perampanel Tablet, Disulfiram - Alcohol Disorders | Phase 1 / Phase 2 | Completed | Virginia Commonwealth University | 4 | 2020-10-15 | 2022-10-07 |
| Safety and Tolerability of Perampanel in Amyotrophic Lateral Sclerosis Patients Fycompa - Amyotrophic Lateral Sclerosis | Phase 2 | Terminated | American University of Beirut Medical Center | 6 | 2019-12-01 | 2021-09-01 |
| Rapid Determination Of The Clinical Utility Of Perampanel For The Treatment Of Alcohol Dependence Perampanel, Placebo - Alcoholism | Phase 1 / Phase 2 | Completed | Virginia Commonwealth University | 22 | 2019-06-01 | 2023-08-18 |
| A Study to Evaluate Efficacy and Safety of Perampanel Administered as an Adjunctive Therapy in Pediatric Participants With Childhood Epilepsy Perampanel Oral Suspension, Perampanel Tablet - Pediatric Epileptic Syndrome, Partial-onset Seizures | Phase 2 | Active not recruiting | Eisai Inc. | 100 | 2019-05-31 | 2026-07-10 |
| A Study of Intravenous Perampanel in Japanese Participants With Epilepsy Perampanel - Epilepsy, Seizures | Phase 2 | Completed | Eisai Co., Ltd. | 21 | 2018-11-27 | 2021-01-05 |
| Safety and Tolerability of Perampanel in Cervical Dystonia Perampanel - Cervical Dystonia | Phase 1 / Phase 2 | Completed | University Health Network, Toronto | 25 | 2017-09-01 | 2020-04-07 |
| Perampanel for Sporadic Amyotrophic Lateral Sclerosis (ALS) Perampanel, placebo - ALS | Phase 2 | Completed | Tokyo Medical University | 66 | 2017-04-24 | 2021-01-15 |
| Pharmacokinetic Study With an Oral Suspension of Perampanel as Adjunctive Therapy in Pediatric Subjects With Epilepsy perampanel - Epilepsy | Phase 2 | Completed | Eisai Inc. | 26 | 2017-02-20 | 2024-03-15 |
| Fycompa in Subjects With Small Fiber Neuropathy (SFN) Fycompa, Placebo - Neuropathy, Small Fiber | Phase 2 | Unknown | PNA Center for Neurological Research | 30 | 2016-01-01 | 2016-01-27 |
| An Efficacy/Safety Study of Perampanel for Reducing Essential Tremor Perampanel, Placebo - Essential Tremor | Phase 2 | Unknown | VA Greater Los Angeles Healthcare System | 16 | 2015-10-01 | 2016-09-12 |
| Pharmacokinetics, Efficacy, and Safety of Perampanel Oral Suspension on Seizure Frequency in Pediatric Subjects Maintained on One to Three Stable Antiepileptic Drugs perampanel - Central Nervous System | Phase 2 | Completed | Eisai Inc. | 63 | 2012-01-01 | 2016-07-12 |
| A Study With an Open-label Extension Phase to Evaluate the Effect of Perampanel (E2007) on Cognition, Growth, Safety, Tolerability, and Pharmacokinetics in Adolescents Perampanel, Placebo - Epilepsy | Phase 2 | Completed | Eisai Inc. | 133 | 2010-09-01 | 2019-05-15 |
| A Long-term Extension Study of E2007 in Patients With Refractory Partial Seizures Uncontrolled With Other Anti-Epileptic Drugs (AEDs) perampanel - Refractory Partial Seizures | Phase 2 | Completed | Eisai Co., Ltd. | 21 | 2009-06-17 | 2018-08-29 |
| An add-on Study of E2007 in Patients With Refractory Partial Seizures Uncontrolled With Other Anti-epileptic Drugs (AEDs) E2007 - Refractory Partial Seizures | Phase 2 | Completed | Eisai Co., Ltd. | 30 | 2009-04-01 | 2013-02-07 |
| Dose-Tolerability Titration Study to Evaluate The Efficacy And Safety Of Perampanel (E2007) In Patients With Post-Herpetic Neuralgia (PHN) E2007 (perampanel), Placebo - Neuralgia | Phase 2 | Completed | Eisai Inc. | 146 | 2008-01-01 | 2013-02-15 |
| Evaluating E2007 (Perampanel) in Patients With Painful Diabetic Neuropathy (PDN) or Post-Herpetic Neuralgia (PHN) E2007 - Neuralgia | Phase 2 / Phase 3 | Completed | Eisai Inc. | 262 | 2008-01-01 | 2016-01-21 |
| Assessment of Perampanel (E2007) on Synaptic Dopamine in Mild-moderate PD Patients: A Pilot Study With [^123I]-IBZM SPECT perampanel, placebo - Parkinson's Disease | Phase 2 | Terminated | Eisai Inc. | 1 | 2007-10-01 | 2018-09-06 |
Showing 20 of 31. Sign in to see all of them.
Epilepsy (10) · Seizures (9) · Parkinson Disease (6) · Neuralgia (2) · Alcohol-Related Disorders (1) · Alcoholism (1) · Amyotrophic Lateral Sclerosis (1) · Bipolar Disorder (1) · Depressive Disorder (1) · Depressive Disorder, Major (1) · Diabetic Neuropathies (1) · Essential Tremor (1) · Glioma (1) · Heart Arrest (1) · Neuralgia, Postherpetic (1)
Eisai Inc. (15) · Eisai Co., Ltd. (5) · Virginia Commonwealth University (2) · American University of Beirut Medical Center (1) · Dana-Farber Cancer Institute (1) · Eisai Limited (1) · PNA Center for Neurological Research (1) · Tokyo Medical University (1) · University Health Network, Toronto (1) · University of California, San Francisco (1) · VA Greater Los Angeles Healthcare System (1) · Yale University (1)
United States (21) · Germany (5) · Czechia (4) · Japan (4) · Latvia (4) · Spain (4) · Belgium (3) · France (3) · Australia (2) · Canada (2) · Italy (2) · Estonia (1) · Finland (1) · Hungary (1) · India (1)
Albert Arias, MD (1) · Albert Arias, MD, PhD (1) · Alessia Nicotra, M.D., Ph.D. (1) · Allison Mann, MD (1) · Antonio Laurenza, M. D. (1) · Antonio Laurenza, M.D. (1) · Charles A Handforth, M.D. (1) · David Squillacote, MD (1) · Edilberto Amorim, MD (1) · Haichen Yang, M.D., M.A. (1) · Hidetaka Hiramatsu (1) · Johnny Salameh, MD (1) · Jonathan Webster (1) · Jong Woo Lee, MD, PhD (1) · Julia Yang, MD, MBA (1)
PMID 35305920, PMID 37059702, PMID 21883097, PMID 22913800, PMID 26724782, PMID 29653338, PMID 30739576, PMID 39499201
R21AA026681 (2), 2004 (1), 2005 (1), 2018 (1), P50CA165962 (1)